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Abstract
Purpose: Endobronchial ultrasound (EBUS) and spiral chest computed tomography (CT) scan are important methods 
in the prediction of infiltrating and non-infiltrating lymph nodes, and the determination of their diagnostic accuracy 
would result in a reduction of the burden of problems and an improvement in prognosis. The purpose in this study 
was to determine the diagnostic accuracy of endobronchial ultrasound and spiral chest CT scan in the prediction of 
infiltrating and non-infiltrating lymph nodes in patients undergoing endobronchial ultrasound.
Material and methods: In this observational prospective study, 40 consecutive patients with infiltrating and non-infil-
trating lymph nodes in Masih-Daneshvari Hospital in 2017 and 2018 were enrolled, and the sensitivity, specificity, 
and accuracy of EBUS and CT-scan versus fine needle aspiration pathology results were determined in them.
Results: The results in this study demonstrated that the congruence between EBUS and CT scan was 80.5%  
(p = 0.0001). The sensitivity, specificity, and accuracy for CT scan were 100%, 22.6%, and 40%, respectively, and the 
sensitivity, specificity, and accuracy for EBUS were 100%, 16.1%, and 35%, respectively.
Conclusion: According to the obtained results, it may be concluded that CT scan and EBUS results have good con-
gruence and high sensitivity to differentiate infiltrating and non-infiltrating lymph nodes. Hence, these methods 
are useful for screening methods, but due to their low specificity and accuracy the use of them for a confirmative 
approach is not beneficial. However, regarding the accessibility and less invasive nature, use of chest CT scan is more 
rational and is recommended in these patients.
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Introduction
Mediastinal and hilar lymphadenopathy is usually diag-
nosed by computerised tomography (CT) scan, which is 
also used for staging, with accuracy and specificity of 57% 
and 82%, respectively [1]. In surgical staging approximate-
ly 18% of patients with a negative CT scan develop meta-
static mediastinal disease [2]. However, all lymph nodes 
may not be detected. In these cases, usually thoracoscopy 
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and anterior mediastinoscopy are used [2]. But all these 
methods for staging are mainly invasive and would result 
in high costs [3,4]. However, the positron emission to-
mography (PET) scan may develop high applicability for 
staging of metastatic lung cancer with lymph node involve-
ment [5], but it is less frequently used due to high costs [6]. 
Endoscopic ultrasound-guided fine needle aspiration 
(FNA) was also introduced; the main limitation for this 
method is the impossibility for airway assessment [7-10].
In this era some studies have reported highest appli-
cability in cases using endobronchial ultrasonography 
(EBUS) with high accuracy in false negative CT scan [11-14]. 
However, there are some controversies about the role of 
the EBUS (Figures 1 and 2) versus spiral chest CT scan 
(Figures 3 and 4) to differentiate between infiltrated and 
none-infiltrated lymph nodes. 
Hence, for improvement in diagnostic approaches, the 
purpose in this study was to determine the diagnostic ac-
curacy of endobronchial ultrasound and spiral chest CT 
scan in the prediction of infiltrating and non-infiltrating 
lymph nodes in patients undergoing endobronchial ultra-
sound.
Material and methods
In this observational prospective study, 40 consecutive 
patients with infiltrating and non-infiltrating lymph 
nodes in Masih-Daneshvari Hospital, Tehran, Iran in 
2017 and 2018, who had positive pathology results by 
biopsy or EBUS but with non-diagnostic spiral chest CT 
scan, were enrolled. The exclusion criterion was incom-
plete data.
The study was approved by the local Ethical Commit-
tee. Data were collected by existing medical documents 
and checklist among understudy patients. Also, the patho-
logical findings including benign and malignant status 
were recorded in the patients. The size and location of the 
lymph nodes were also determined.
Data analysis was done with SPSS software (Version 
25.0), and mean plus standard deviation were calculated 
for numerical variables, and the frequency and percentage 
were reported for categorical factors. Kappa test was used 
to determine the congruence, and the sensitivity, speci-
ficity, and accuracy was calculated. P values less than 0.05 
were considered statistically significant.
Figure 1. Endobronchial ultrasound fine needle aspiration paratracheal 
lymph node
Figure 2. Endobronchial ultrasound fine needle aspiration hilar lymph node
Figure 3. Hilar lymph nodes in axial computed tomography
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Results
The patient’s age was under 50 years in 17 cases (42.5%). 
The gender was male in 15 patients (37.5%). The CT 
scan results were positive in 33 patients (82.5%), and 
the EBUS was positive in 35 cases (87.5%). According 
to the pathological results, 31 cases (77.5%) were be-
nign. The mean lymph node size was 10.7 mm in CT and 
11 mm in EBUS without difference between benign or 
malignant lesions (p > 0.05). Also, the total range was 
from 6 to 25 mm.
The results in this study (Table 1) show that the 
congruence between EBUS and CT scan was 80.5% 
(p = 0.0001). The sensitivity, specificity, and accuracy for 
CT scan was 100%, 22.6%, and 40%, respectively (Table 2) 
and the sensitivity, specificity, and accuracy for EBUS was 
100%, 16.1%, and 35%, respectively (Table 3).
The congruence did not differ according to age, and 
patients younger and older than 50 years had good con-
gruence between EBUS and CT scan. Also, the congru-
ence did not differ according to gender, and both male 
and female patients had good congruence between EBUS 
and CT scan. The congruence was good in benign cases 
(p = 0.0001), but it was not determined according to the lo-
cation, malignancy, and stage of the malignancy (p > 0.05).
Discussion
The main utilised method to diagnose mediastinal lym-
phadenopathy is CT scan, but it would show low accuracy. 
The highest applicability point is related to EBUS. How-
ever, there are some controversies. Because CT scan is 
a non-invasive method, in this study the accuracy of EBUS 
and spiral CT scan was assessed. The congruence of meth-
ods was 80.5% and significant. The sensitivity for methods 
was 100% and the specificity was near to 20% with accura-
cy rate of 35 to 40%. Age and gender subgroups both had 
good equal concordances. The congruence was higher in 
benign lesions. It is not clear in malignant lesions. Also, 
Figure 4. Hilar and subcarinal lymph nodes in coronal computed tomography
Table 1. Congruence between computed tomography scan and endobron-
chial ultrasound results
CT Total
Pos Neg
EBUS Pos Count 33 2 35
% within EBUS 94.3% 5.7% 100%
% within CT 100% 28.6% 87.5%
Neg Count 0 5 5
% within EBUS 0 100% 100%
% within CT 0 71.4% 12.5%
Total Count 33 7 40
% within EBUS 82.5% 17.5% 100%
% within CT 100% 100% 100%
Table 2. Computed tomography scan sensitivity, specificity, and accuracy
Pathological result Total
Benign Malignant
EBUS Pos Count 24 9 33
% within CT 72.7% 27.3% 100%
% within 77.4% 100% 82.5%
Pathological result
Neg Count 7 0 7
% within CT 100% 0 100%
% within 22.6% 0 17.5%
Pathological result
Total Count 31 9 40
% within CT 77.5% 22.5% 100%
% within 100% 100% 100%
Pathological result
the location and stage effects were impossible to deter-
mine. Udoji et al. [15] reported that lymph nodes had larg-
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Table 3. Endobronchial ultrasound sensitivity, specificity, and accuracy
Pathological result Total
Benign Malignant
EBUS Pos Count 26 9 35
% within  EBUS 74.3% 27.5% 100%
% within 83.9% 100% 87.5%
Pathological result
Neg Count 5 0 5
% within  EBUS 100% 0 100%
% within 16.1% 0 12.5%
Pathological result
Total Count 31 9 40
% within  EBUS 77.5% 22.5% 100%
% within 100% 100% 100%
Pathological result
er size in EBUS versus CT scan assessment. In our study, 
despite a lack of difference between benign and malignant 
lesions, it was larger in EBUS evaluation.
Helmy et al. [16] assessed 11 patients who were sus-
pected of having lymph node malignancy without CT scan 
positive results. The malignancy was reported in 54.4% of 
cases under bronchoscopy, 18.2% under EBUS-TBNA, and 
27.3% under CT-guided biopsy. From 11 cases with nega-
tive CT scan the EBUS was positive in four patients [16]. 
In our study the malignancy rate was lower, but similarly 
EBUS had good applicability.
Nakajima et al. [17] showed that among 106 patients 
with metastatic lung cancer the sensitivity and specificity 
were 92% and 100%, respectively. Their sensitivity and 
specificity were lower and higher than ours, respectively. 
Memoli et al. [18] reported malignancy in lymph nodes 
in 22.5% of cases and reported good diagnostic applica-
bility for both CT scan and EBUS method as well as our 
study.
Jhun et al. [19] reported sensitivity and specificity of 
92% and 99%, respectively, for EBUS, which was related 
to lymph node location. However, in our study, due to the 
small number of hilar samples, a comparison was impos-
sible. Lee et al. [20] assessed 247 patients with hilar and 
mediastinal lymphadenopathy and reported that older 
age and pathological results were related to higher false 
negative rates. In our study the benign status had some 
effects on congruence between methods, but there was no 
difference for age.
According to the obtained results it may be concluded 
that CT scan and EBUS results have good congruence and 
high sensitivity to differentiate infiltrating and non-infil-
trating lymph nodes. Hence, these methods are useful for 
screening methods, but due to their low specificity and ac-
curacy their use for a confirmative approach is not benefi-
cial. However, regarding its accessibility and less invasive 
nature, the use of chest CT scan is more rational and is 
recommended in these patients. However further studies 
with larger sample sizes and controlling for confounding 
factors would develop more definite results.
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